You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dolutegravir/lamivudine

Showing 1 - 25 of 597
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Liège (Treatment simplification (dolutegravir lamivudine))

Active, not recruiting
  • HIV Infections
  • Treatment simplification (dolutegravir lamivudine)
  • Liège, Belgium
    Liège university hospital
Apr 27, 2022

AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))

Not yet recruiting
  • Acquired Immunodeficiency Syndrome
  • Dolutegravir 50 MG plus lamivudine 300 MG； Dolutegravir/lamivudine (50 MG/300 MG)
  • (no location specified)
Aug 6, 2022

HIV, HIV Trial (Dolutegravir, Lamivudine, Bictegravir)

Not yet recruiting
  • HIV
  • HIV Infections
  • (no location specified)
Aug 4, 2023

HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

Active, not recruiting
  • HIV I Infection
  • Dolutegravir / Lamivudine Pill
  • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
  • Orlando, Florida
    Orlando Immunology Center
Sep 20, 2022

HIV-1-infection Trial in Argentina, Brazil (Intervention Arm: dolutegravir/lamivudine, Comparator ARM: TDF/XTC plus Dolutegravir

Recruiting
  • HIV-1-infection
  • Intervention Arm: dolutegravir/lamivudine
  • Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
  • Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina
  • +7 more
Jun 29, 2022

HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)

Withdrawn
  • HIV-1 Infection
  • Dolutegravir plus lamivudine
  • Caba, Buenos Aires, Argentina
  • +1 more
Apr 5, 2022

Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

Active, not recruiting
  • Hiv
  • HIV-1-infection
  • Lamivudine 300 MG
  • Emtricitabine / Tenofovir Disoproxil Pill
  • Buenos Aires, Argentina
    Fundacion IDEAA
Jan 2, 2023

HIV, Drug Resistance, Drug Drug Interaction Trial in Switzerland (DOR/DTG/3TC)

Not yet recruiting
  • HIV
  • +2 more
  • Basel, Switzerland
  • +6 more
Sep 7, 2023

HIV Trial in Spain (Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato])

Active, not recruiting
  • HIV Infections
  • Dolutegravir 50 MG / Lamivudine 300 MG Oral Tablet [Dovato]
  • Vigo, Pontevedra, Spain
  • +16 more
Jun 20, 2022

Human Immunodeficiency Virus Trial in Newark (Dolutegravir/Lamivudine)

Active, not recruiting
  • Human Immunodeficiency Virus
  • Dolutegravir/Lamivudine
  • Newark, New Jersey
    Saint Michael's Medical Center
May 3, 2022

HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

Not yet recruiting
  • HIV Infections
  • (no location specified)
Jun 13, 2023

HIV-1-infection Trial in Montréal (abacavir, dolutegravir and lamivudine dispersible tablets, Triumeq Dispersible Tablets 5 mg

Completed
  • HIV-1-infection
  • abacavir, dolutegravir and lamivudine dispersible tablets
  • Triumeq Dispersible Tablets 5 mg GSK1349572 [Dolutegravir]/ 60 mg Abacavir/ 30 mg Lamivudine
  • Montréal, Quebec, Canada
    Altasciences
Mar 10, 2022

HIV Trial in Austin (TRIUMEQ, DOVATO)

Completed
  • HIV Infections
  • Austin, Texas
    GSK Investigational Site
Sep 21, 2021

Hiv, HIV, HIV Lipodystrophy Trial in Denmark (Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO],

Recruiting
  • Hiv
  • +6 more
  • Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]
  • Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]
  • Aalborg, Denmark
  • +4 more
May 21, 2021

Hiv, HIV, HIV Cardiomyopathy Trial in Denmark (Dolutegravir / Lamivudine Oral Tablet)

Recruiting
  • Hiv
  • +5 more
  • Dolutegravir / Lamivudine Oral Tablet
  • Aalborg, Denmark
  • +4 more
May 26, 2021

HIV-1-infection Trial in Italy (DOVATO)

Recruiting
  • HIV-1-infection
  • Bari, BA, Italy
  • +24 more
Jul 16, 2021

HIV-1 Infection Trial in Germany, Netherlands (Atazanavir, Dolutegravir, Lamivudine)

Terminated
  • HIV-1 Infection
  • Bonn, Germany
  • +3 more
Dec 4, 2020

HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)

Completed
Has Results
  • HIV
  • Acute HIV Infection
  • Dolutegravir 50 mg
  • +2 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 22, 2021

Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy

Active, not recruiting
  • HIV Infections
  • Cultural Domain Analysis
  • +2 more
  • Brighton, United Kingdom
    Royal Sussex County Hospital, Brighton, UK
May 18, 2022

Dolutegravir Plus Lamivudine Simplified Therapy

Recruiting
  • HIV/AIDS
  • DTG+ 3TC
  • Guangzhou, Guangdong, China
    Guangzhou 8th People's Hospital
Jul 19, 2021

HIV, AIDS, Virologic Failure Trial (Maintenance on TLD treatment strategy, Individualized Care treatment strategy, Immediate

Not yet recruiting
  • HIV Infections
  • +2 more
  • Maintenance on TLD treatment strategy
  • +2 more
  • (no location specified)
May 9, 2022

REal-Life Cohort With DOlutegravir + LAmivudina

Recruiting
  • HIV-1-infection
  • Dolutegravir 50 MG
  • Lamivudine 300 MG
  • Madrid, Spain
    Alfonso Cabello
Apr 5, 2021

HIV-1 Infection Trial in Yaoundé (Dolutegravir 50 mg, Tenofovir disoproxil fumarate 300 mg / lamivudine 300 mg, Efavirenz 400

Completed
  • HIV-1 Infection
  • Dolutegravir 50 mg
  • +2 more
  • Yaoundé, Cameroon
  • +2 more
Aug 26, 2021

HIV Trial in United States (Dolutegravir + Lamivudine FDC)

Completed
Has Results
  • HIV Infections
  • Dolutegravir + Lamivudine FDC
  • Birmingham, Alabama
  • +15 more
Sep 20, 2021

HIV, Pregnancy Related, Mother to Child Transmission Trial in Salvador (Dolutegravir plus lamivudine in a FDC)

Recruiting
  • HIV Infections
  • +2 more
  • Dolutegravir plus lamivudine in a FDC
  • Salvador, BA, Brazil
    Fundação Bahiana de Infectologia
Feb 3, 2022